To assess the effect of saroglitazar and pioglitazone on non alcoholic fatty liver disease in type 2 diabetes mellitus patients

Abstract

Abstract is not available. newline

Description

Keywords

Citation

item.page.endorsement

item.page.review

item.page.supplemented

item.page.referenced